2026 ICD-10-CM Diagnosis Code Z29.11Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)
Z29.11 is a billable ICD-10-CM diagnosis code for encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV). It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Encounter for prophylactic measures (excludes immunization).
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z29.11.
Present on Admission (POA)Billing
Z29.11 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Encounter(with health service) (for)
- prophylactic measures
- immunotherapy for respiratory syncytial virus (RSV)
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert Z29.11 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code History & ChangesHistory
Replacement Z29.11 replaces the following previously assigned code(s):
- Z23 - Encounter for immunization
Questions About Z29.11Overview
Is Z29.11 (Encounter for prophylactic immunotherapy) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Can Z29.11 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z29.11 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) on inpatient claims.
What is the ICD-9 equivalent of Z29.11?
Under the General Equivalence Mappings, encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) converts to ICD-9-CM V07.2 (prophylact immunotherapy). The mapping is approximate, so confirm the match fits the documentation.
